Skip to main content
Fig. 1 | Journal of Pharmaceutical Health Care and Sciences

Fig. 1

From: Effects of polymorphic cytochrome P450 2A6 genotypes on chemoprevention against colorectal tumors in single Japanese cohort using daily low-dose aspirin: insights into future personalized treatments

Fig. 1

Effects of CYP2A6 haplotypes and genotypes on aspirin chemoprevention for colorectal tumor recurrence in the total cohort and the nonsmoker subset of Japanese J-CAPP study participants. Data shown in Panel A of adjusted odds ratios by sex, age, and the number of tumors prior to the trial were taken from Ishikawa et al. [9]. The preventive effects of aspirin were evaluated based on the recurrence of polyps observed in 2 years in the J-CAPP study. Odds ratios are shown with respect to the reference (placebo) group

Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us